SCHEMBL585047

SCHEMBL585047

O=S(=O)(O)C1CCCC2CCCCC21

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21214994 0.82 ALDH1A1 (0.30) ALDH1A1
SCHEMBL1878592 0.78
SCHEMBL27708508 0.77 CA1 (0.37) ALDH1A1
SCHEMBL27769894 0.77 TSHR (0.38)
SCHEMBL14426484 0.77
SCHEMBL10753587 0.77 GRM5 (0.30)
SCHEMBL28000668 0.75 CA1 (0.38) ALDH1A1
SCHEMBL14626486 0.74 ACHE (0.30)
SCHEMBL28933940 0.70 TSHR (0.33)
SCHEMBL17717468 0.70 MAPT (0.38) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4456492-A MELT OF OXYGEN RELEASING SALT, FUEL MATERIALS, AND AMMONIUM NITRATE ICI AUSTRALIA LIMITED (AU) 1984-06-26 US claimed
EP-3819341-B1 URETHANE RESIN COMPOSITION AND LAYERED PRODUCT DAINIPPON INK & CHEMICALS (JP) 2023-11-22 EP disclosed
US-20220169887-A1 URETHANE RESIN COMPOSITION AND LAYERED PRODUCT DIC CORPORATION (JP) 2022-06-02 US disclosed
EP-3943537-A1 URETHANE RESIN COMPOSITION AND LAYERED PRODUCT DIC Corporation (JP) 2022-01-26 EP disclosed
EP-3819341-A1 URETHANE RESIN COMPOSITION AND LAYERED PRODUCT DIC Corporation (JP) 2021-05-12 EP disclosed
EP-3770225-A1 AQUEOUS INK COMPOSITION, INK SET, AND IMAGE FORMING METHOD Fujifilm Corporation (JP) 2021-01-27 EP disclosed
US-10035795-B1 Phenothiazine derivatives having CaM inhibitory activity KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-07-31 US disclosed
US-20170130162-A1 High Performance Lubricating Compositions UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2017-05-11 US disclosed
US-8749955-B2 Capacitor PANASONIC CORPORATION (JP) 2014-06-10 US disclosed
US-20140133068-A1 CAPACITOR PANASONIC CORPORATION (JP) 2014-05-15 US disclosed
US-5851682-A Polyolefin resin composition and resin film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-12-22 US disclosed
EP-0795789-A1 Negative type image recording material FUJI PHOTO FILM CO., LTD. (JP) 1997-09-17 EP disclosed
EP-0489925-B1 PYRIMIDINE COMPOUND AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF MITSUI PETROCHEMICAL IND (JP) 1996-06-12 EP disclosed
EP-0705880-A1 POLYOLEFIN RESIN COMPOSITION AND RESIN FILM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1996-04-10 EP disclosed
US-5358945-A For treatment of nervous system disorders MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1994-10-25 US disclosed
EP-0489925-A1 PYRIMIDINE COMPOUND AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1992-06-17 EP disclosed
US-4618678-A 4-(2,3-dichloro-6-fluorophenyl)-1,4,5,6,7,8-hexahydro-2-methyl-5-oxo-1,7-naphthyridine-3-carboxylic acid 2-(2,3-dichlorophenoxy)ethyl ester AMERICAN HOME PRODUCTS CORPORATION (US) 1986-10-21 US disclosed
US-4474794-A N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds ELI LILLY AND COMPANY (US) 1984-10-02 US disclosed
EP-0056907-A1 Process for the preparation of suède-like raised fabrics TEIJIN LIMITED (JP) 1982-08-04 EP disclosed
US-4205991-A COLORS, SOLVENTS, INKS CIBA-GEIGY AG (CH) 1980-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035795-B1 Phenothiazine derivatives having CaM inhibitory activity CALM1, CAMK4, CAMK1 ALDH1A1 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.